0 followers
Vibliome Therapeutics, LLC, has developed a novel systematic approach that enables the design of small molecule kinase inhibitors with unique selectivity profiles and extraordinary selectivity.
Robert Goodwin
Curia Global
4 followers
Lenz Therapeutics
3 followers
Rocket Pharmaceuticals
2 followers
Amplity Health
1 follower
LabConnect
1 follower
SurveyMonkey
81 followers
Earth Advantage
56 followers
Organon
15 followers
NYU Langone Health
13 followers
Apellis Pharmaceuticals
8 followers
West Pharmaceutical Services
6 followers
Explore companies